These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 2484687

  • 1. Modulation of platelet function by SIN-1A, a metabolite of molsidomine.
    Wautier JL, Weill D, Kadeva H, Maclouf J, Soria C.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S111-4. PubMed ID: 2484687
    [Abstract] [Full Text] [Related]

  • 2. [Role of molsidomine on platelet activation in coronary ischemia].
    Wautier JL.
    Presse Med; 1988 May 25; 17(20):1037-40. PubMed ID: 2969100
    [Abstract] [Full Text] [Related]

  • 3. The effects of molsidomine and its metabolite SIN-1 on coronary vessel tone, platelet aggregation, and eicosanoid formation in vitro--inhibition of 12-HPETE biosynthesis.
    Darius H, Ahland B, Rücker W, Klaus W, Peskar BA, Schrör K.
    J Cardiovasc Pharmacol; 1984 May 25; 6(1):115-21. PubMed ID: 6199592
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo.
    Gerzer R, Drummer C, Karrenbrock B, Heim JM.
    J Cardiovasc Pharmacol; 1989 May 25; 14 Suppl 11():S115-9. PubMed ID: 2484688
    [Abstract] [Full Text] [Related]

  • 5. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
    Block HU, Förster W, Heinroth I.
    Arzneimittelforschung; 1982 May 25; 32(3):189-94. PubMed ID: 6896278
    [Abstract] [Full Text] [Related]

  • 6. Influence of the direct NO-donor SIN-1 on the interaction between platelets and stainless steel stents under dynamic conditions.
    Jung F, Mrowietz C, Seyfert UT, Grewe R, Franke RP.
    Clin Hemorheol Microcirc; 2003 May 25; 28(4):189-99. PubMed ID: 12897410
    [Abstract] [Full Text] [Related]

  • 7. Interaction between SIN-1 and prostacyclin in inhibiting platelet aggregation.
    Bult H, Fret HR, Herman AG.
    J Cardiovasc Pharmacol; 1989 May 25; 14 Suppl 11():S120-3. PubMed ID: 2484689
    [Abstract] [Full Text] [Related]

  • 8. Anti-ischemic actions of molsidomine by venous and large coronary dilatation in combination with antiplatelet effects.
    Bassenge E, Mülsch A.
    J Cardiovasc Pharmacol; 1989 May 25; 14 Suppl 11():S23-8. PubMed ID: 2484695
    [Abstract] [Full Text] [Related]

  • 9. The influence of molsidomine and its active metabolite SIN-1 on fibrinolysis and platelet aggregation.
    Basista M, Grodzińska L, Swies J.
    Thromb Haemost; 1985 Dec 17; 54(4):746-9. PubMed ID: 3911480
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation.
    Lecut C, Schoolmeester A, Kuijpers MJ, Broers JL, van Zandvoort MA, Vanhoorelbeke K, Deckmyn H, Jandrot-Perrus M, Heemskerk JW.
    Arterioscler Thromb Vasc Biol; 2004 Sep 17; 24(9):1727-33. PubMed ID: 15231520
    [Abstract] [Full Text] [Related]

  • 12. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
    Nunez D, Russo-Marie F, Benveniste J.
    Pathol Biol (Paris); 1987 Feb 17; 35(2 Pt 2):215. PubMed ID: 3550639
    [Abstract] [Full Text] [Related]

  • 13. [Molsidomine: importance in treatment of circulation disorders].
    Kmieć M, Ochmański W.
    Przegl Lek; 1998 Feb 17; 55(10):532-6. PubMed ID: 10224868
    [Abstract] [Full Text] [Related]

  • 14. The antiplatelet effects of a new nitroderivative of acetylsalicylic acid--an in vitro study of inhibition on the early phase of platelet activation and on TXA2 production.
    Lechi C, Andrioli G, Gaino S, Tommasoli R, Zuliani V, Ortolani R, Degan M, Benoni G, Bellavite P, Lechi A, Minuz P.
    Thromb Haemost; 1996 Nov 17; 76(5):791-8. PubMed ID: 8950792
    [Abstract] [Full Text] [Related]

  • 15. The antithrombotic effect of thromboxane receptor antagonist HN 11500 on thrombus formation in laser thrombosis model and platelet function tests.
    Krupiński K, Ferber H, Breddin HK, Bielawiec M.
    Acta Haematol Pol; 1994 Nov 17; 25(3):235-42. PubMed ID: 7992596
    [Abstract] [Full Text] [Related]

  • 16. alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.
    Hsiao G, Chang CY, Shen MY, Chou DS, Tzeng SH, Chen TF, Sheu JR.
    J Agric Food Chem; 2005 Jun 29; 53(13):5179-86. PubMed ID: 15969494
    [Abstract] [Full Text] [Related]

  • 17. Differential effect of SIN-1 on thromboxane and prostacyclin formation in platelets and endothelial cells.
    Lagarde M, Bordet JC, Croset M.
    J Cardiovasc Pharmacol; 1989 Jun 29; 14 Suppl 11():S95-7. PubMed ID: 2484709
    [Abstract] [Full Text] [Related]

  • 18. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
    Salvemini D, Currie MG, Mollace V.
    J Clin Invest; 1996 Jun 01; 97(11):2562-8. PubMed ID: 8647949
    [Abstract] [Full Text] [Related]

  • 19. Oxygen and oxidation promote the release of nitric oxide from sydnonimines.
    Bohn H, Schönafinger K.
    J Cardiovasc Pharmacol; 1989 Jun 01; 14 Suppl 11():S6-12. PubMed ID: 2484701
    [Abstract] [Full Text] [Related]

  • 20. 2'-Ethoxy-5'-methoxy-2-(5-methylthienyl)chalcone inhibits collagen-induced protein tyrosine phosphorylation and thromboxane formation during platelet aggregation and adhesion.
    Lo HM, Huang TF, Lin CN, Peng HC, Wu WB.
    Pharmacology; 2009 Jun 01; 84(3):145-52. PubMed ID: 19690443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.